Dr. Vibhu Awasthi has been given a notice of grant award by NIH National Cancer Institute for his project "Pancreatic cancer therapy with GRP receptor-targeted imageable diphenyl difluoroketone." This R03 grant award is for 2 years in the amount of $146,500. Congratulations Dr. Awasthi!